Back to companies
Seres Therapeutics, Inc.
MCRBUSNASDAQPharmaceuticals & HealthcareSeres Therapeutics, Inc.
Revenue
$789,000
FY2025
Operating income
-$94.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API